Impact of Discontinuation of Denosumab on Bone Health in Breast Cancer Patients

被引：0
|
作者：
Tannenbaum, Susan
Soto, Alvaro Alvarez
Taxel, Pamela
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-12-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-12-02
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Denosumab in Breast Cancer
    Allan Lipton
    Current Oncology Reports, 2011, 13 : 1 - 4
  • [32] Denosumab Experience in Lung Cancer Patients with Bone Metastases
    Erdem, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S951 - S951
  • [33] Bisphophonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
    Belen Zanchetta, Maria
    Pelegrin, Carolina
    Silveira, Fernando
    Bogado, Cesar
    Zanchetta, Jose
    Salerni, Helena
    Costanzo, Pablo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 114 - 115
  • [34] Bone Matrix Mineralization After Denosumab Treatment Discontinuation.
    Brown, Jacques
    Dempster, David
    Yue, Susan
    Rizzo, Sebastien
    Farlay, Delphine
    Wagman, Rachel
    Yin, Xiang
    Boivin, Georges
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S406 - S406
  • [35] Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials
    Galvano, Antonio
    Scaturro, Dalila
    Badalamenti, Giuseppe
    Incorvaia, Lorena
    Rizzo, Sergio
    Castellana, Luisa
    Cusenza, Stefania
    Cutaia, Sofia
    Santini, Daniele
    Guadagni, Fiorella
    Roselli, Mario
    Gori, Stefania
    Latteri, Mario Adelfio
    Bazan, Viviana
    Giulia, Letizia Mauro
    Russo, Antonio
    JOURNAL OF BONE ONCOLOGY, 2019, 18
  • [36] IMPACT OF DENOSUMAB ON BONE MINERAL DENSITY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
    Eremkina, A.
    Gorbacheva, A.
    Krupinova, J.
    Bibik, E.
    Knyaseva, O.
    Sasonova, N.
    Mokrysheva, N.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S355 - S356
  • [37] Denosumab for Bone Metastases From Breast Cancer: A New Therapy Option?
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) : E419 - E420
  • [38] Denosumab and the current status of bone-modifying drugs in breast cancer
    Lee, Brittany L.
    Higgins, Michaela J.
    Goss, Paul E.
    ACTA ONCOLOGICA, 2012, 51 (02) : 157 - 167
  • [39] Bone health in breast cancer
    Pandey, Praful
    Sharma, Aparna
    Gogia, Ajay
    CURRENT PROBLEMS IN CANCER, 2023, 47 (03)
  • [40] The effect of denosumab on kidney function in patients with metastatic breast cancer to bone previously treated with zoledronic acid
    Purvey, Sneha
    Leventakos, Konstantinos
    Munjoma, Mutsa S.
    Sherman, Michael J.
    Desale, Sameer
    Herbolshelmer, Pla Maarit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345